A possible risk effect was shown for both GABRP SNPs rs11743438 and rs11743735: a significantly higher rate of homozygous patients for the variant allele (v/v) was recorded among the patients with hepatitis, 75% and 71.4%, respectively, than among those without hepatitis, 32.8% and 21.4, respectively (p = 0.046; p = 0.013, Table 5). Here, GABRP is linked to Hepatitis.